A retrospective study in JMCP found that pharmacist-adjudicated prior authorization drug requests result in substantial economic benefit, and the prevention of adverse events.
In diabetic patients, treatment intensification with insulin or GLP-1RA after failure of two oral anti-diabetic agents resulted in improved glycemic control, according to a retrospective cohort published in JMCP.